NAPSA
From Wikipedia, the free encyclopedia
Napsin A aspartic peptidase
|
|||||||||||
Identifiers | |||||||||||
Symbol(s) | NAPSA; KAP; NAP1; NAPA; SNAPA; Kdap | ||||||||||
External IDs | OMIM: 605631 MGI: 109365 HomoloGene: 68418 | ||||||||||
|
|||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 9476 | 16541 | |||||||||
Ensembl | ENSG00000131400 | ENSMUSG00000002204 | |||||||||
Uniprot | O96009 | Q3TDT8 | |||||||||
Refseq | NM_004851 (mRNA) NP_004842 (protein) |
NM_008437 (mRNA) NP_032463 (protein) |
|||||||||
Location | Chr 19: 55.55 - 55.56 Mb | Chr 7: 44.44 - 44.45 Mb | |||||||||
Pubmed search | [1] | [2] |
Napsin A aspartic peptidase, also known as NAPSA, is a human gene.[1]
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.[1]
[edit] References
[edit] Further reading
- Koelsch G, Mares M, Metcalf P, Fusek M (1994). "Multiple functions of pro-parts of aspartic proteinase zymogens.". FEBS Lett. 343 (1): 6-10. PMID 8163018.
- Blundell TL, Guruprasad K, Albert A, et al. (1998). "The aspartic proteinases. An historical overview.". Adv. Exp. Med. Biol. 436: 1-13. PMID 9561193.
- Tatnell PJ, Powell DJ, Hill J, et al. (1999). "Napsins: new human aspartic proteinases. Distinction between two closely related genes.". FEBS Lett. 441 (1): 43-8. PMID 9877162.
- Chuman Y, Bergman A, Ueno T, et al. (2000). "Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.". FEBS Lett. 462 (1-2): 129-34. PMID 10580105.
- Schauer-Vukasinovic V, Bur D, Kling D, et al. (2000). "Human napsin A: expression, immunochemical detection, and tissue localization.". FEBS Lett. 462 (1-2): 135-9. PMID 10580106.
- Yan R, Bienkowski MJ, Shuck ME, et al. (1999). "Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.". Nature 402 (6761): 533-7. doi: . PMID 10591213.
- Cook M, Bühling F, Ansorge S, et al. (2002). "Pronapsin A and B gene expression in normal and malignant human lung and mononuclear blood cells.". Biochim. Biophys. Acta 1577 (1): 10-6. PMID 12151090.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Ueno T, Linder S, Elmberger G (2004). "Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.". Br. J. Cancer 88 (8): 1229-33. doi: . PMID 12698189.
- Brasch F, Ochs M, Kahne T, et al. (2004). "Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung.". J. Biol. Chem. 278 (49): 49006-14. doi: . PMID 13129928.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi: . PMID 14702039.
- Innocenti M, Zucconi A, Disanza A, et al. (2004). "Abi1 is essential for the formation and activation of a WAVE2 signalling complex.". Nat. Cell Biol. 6 (4): 319-27. doi: . PMID 15048123.